Publication date: Sep 06, 2024
We have learned that the story of COVID-19 is not so simple [. ..].
Open Access PDF
| Concepts | Keywords |
|---|---|
| 2nd | 2nd |
| Basel | Basel |
| Covid | Clinical |
| Learned | Covid |
| Edition | |
| Learned | |
| Prevention | |
| Simple | |
| Story | |
| Treatment |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | infection |
| disease | MESH | inflammation |
| drug | DRUGBANK | Omalizumab |
| drug | DRUGBANK | Mepolizumab |
| drug | DRUGBANK | Benralizumab |
| drug | DRUGBANK | Dupilumab |
| drug | DRUGBANK | Tocilizumab |
| disease | MESH | complications |
| disease | MESH | ageusia |
| disease | IDO | symptom |
| disease | IDO | history |
| disease | MESH | Fungal Infections |
| disease | MESH | Critically Ill |
| disease | MESH | Acute Renal Failure |
| disease | MESH | Myasthenia Gravis |
| drug | DRUGBANK | Guanosine |
| drug | DRUGBANK | Carboxyamidotriazole |
Original Article
(Visited 3 times, 1 visits today)